FDA Approves Lotemax SM For Ocular Surgery Pain, Inflammation

The FDA has approved a new formulation of loteprednol etabonate ophthalmic gel (Lotemax SM, Bausch + Lomb) 0.38% for postoperative inflammation and pain following ocular surgery.
FDA Approvals

Full Story →